INTERNATIONAL PATENT: INTELLIA THERAPEUTICS, INC. FILES APPLICATION FOR "METHODS FOR EDITING HLA-A IN CELLS PRE-SCREENED FOR THE ABSENCE OF ONE OR BOTH ALLELES OF HLA-H*01"

GENEVA, March 10 -- INTELLIA THERAPEUTICS, INC. (40 Erie StreetCambridge, MA 02139) filed a patent application (PCT/US2024/043972) for "METHODS FOR EDITING HLA-A IN CELLS PRE-SCREENED FOR THE ABSENCE OF ONE OR BOTH ALLELES OF HLA-H*01" on Aug 27, 2024. With publication no. WO/2025/049432, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SCHULTES, Birgit (C/o Intellia Therapeutics, Inc.40 Erie StreetCambridge, MA 02139), ZHANG, Yong (C/o Intellia Therapeutics, Inc.40 Erie StreetCambridge, MA 02139), HAN, Bo (C/o Intellia Th...